sur Viemed Healthcare, Inc. (NASDAQ:VMD)
Viemed Healthcare Reports Strong Q1 2026 Financial Results
Viemed Healthcare, a provider of home-based healthcare solutions, announced its financial performance for Q1 2026. Revenues reached $75.4 million, a 28% increase from the previous year. Net income was $2.6 million, translating to $0.06 per diluted share. Adjusted EBITDA totaled $14.3 million, a 12% rise over Q1 2025.
The company reported $8.1 million in operating cash flow for the quarter, with free cash flow of $2.6 million. Viemed repurchased 150,000 common shares for $1.4 million. Patient counts for ventilator and PAP therapy increased by 2% and 57% respectively year-over-year.
Viemed has updated its 2026 guidance, projecting net revenue between $312 million and $320 million, with adjusted EBITDA ranging from $65 million to $69 million. The company's cash balance stood at $9.8 million, with long-term debt at $8.3 million.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Viemed Healthcare, Inc.